Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Korakoth Towashiraporn & Rungroj Krittayaphong. (2022) Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome. International Journal of General Medicine 15, pages 2397-2414.
Read now
Read now
Aaron E. Brice, Gabriel A. Hernandez, Mariluz Sanchez, Marshall Haynick & Cesar E. Mendoza. (2017) In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention. Platelets 28:3, pages 305-309.
Read now
Read now
Estella M Davis, Jon T Knezevich & Robyn M Teply. (2013) Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor. Clinical Pharmacology: Advances and Applications 5, pages 67-83.
Read now
Read now
Nicholas B. Norgard & James J. DiNicolantonio. (2013) Clopidogrel, Prasugrel, or Ticagrelor? A Practical Guide to Use of Antiplatelet Agents in Patients With Acute Coronary Syndromes. Postgraduate Medicine 125:4, pages 91-102.
Read now
Read now
Articles from other publishers (12)
Nanang Fakhrudin, Krisna Kharisma Pertiwi, Marce Inggrita Takubessi, Eka Fitri Susiani, Arief Nurrochmad, Sitarina Widyarini, Ari Sudarmanto, Arief Adi Nugroho & Subagus Wahyuono. (2020) A geranylated chalcone with antiplatelet activity from the leaves of breadfruit (Artocarpus altilis). Pharmacia 67:4, pages 173-180.
Crossref
Crossref
Mohammad Umar Farooq. (2020) Ticagrelor: A Safe Option as Part of Triple Therapy?. Clinics and Practice 10:1, pages 1221.
Crossref
Crossref
Saurabh Gupta, Emilie P. Belley-Cote, Parisa Agahi, Ameen Basha, Iqbal Jaffer, Shamir Mehta, J-D Schwalm & Richard P. Whitlock. (2019) Antiplatelet Therapy and Coronary Artery Bypass Grafting: Analysis of Current Evidence With a Focus on Acute Coronary Syndrome. Canadian Journal of Cardiology 35:8, pages 1030-1038.
Crossref
Crossref
Soo-In Chae, Hee Jo Yoo, Su-Yeon Lee, Eun Kyoung Chung, Wang-Seob Shim & Kyung-Tae Lee. (2019) Development and Validation of Simple LC–MS-MS Assay for the Quantitative Determination of Ticagrelor in Human Plasma: its Application to a Bioequivalence Study. Journal of Chromatographic Science 57:4, pages 331-338.
Crossref
Crossref
Renli Teng, Sharen Muldowney, Yonggang Zhao, Jolene Kay Berg, Jonathan Lu & Naeem D. Khan. (2018) Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function. European Journal of Clinical Pharmacology 74:9, pages 1141-1148.
Crossref
Crossref
Niccolò Lombardi, Ersilia Lucenteforte, Monica Torrini, Daniela Balzi, Alessandro Barchielli, Alessandro Mugelli & Alfredo Vannacci. (2018) Ticagrelor-related late-onset dyspnea as cause of emergency department visit: a 3-year outpatient study. Journal of Cardiovascular Medicine 19:6, pages 284-289.
Crossref
Crossref
Jamshed J. Dalal, Aarti Digrajkar & Alap Gandhi. (2016) Oral antiplatelet therapy and platelet inhibition: An experience from a tertiary care center. Indian Heart Journal 68:5, pages 624-631.
Crossref
Crossref
Mohamed Subhan Anwar, Muhammad Zaid Iskandar, Helen M Parry, Alex S Doney, Colin N Palmer & Chim C Lang. (2015) The future of pharmacogenetics in the treatment of heart failure. Pharmacogenomics 16:16, pages 1817-1827.
Crossref
Crossref
Jason C. Simeone, Cliff Molife, Elizabeth Marrett, Feride Frech-Tamas, Mark B. Effron, Beth L. Nordstrom, Yajun E. Zhu, Stuart Keller, Brian R. Murphy, Kavita V. Nair, George W. Vetrovec, Robert L. PageIIII & Patrick L. McCollam. (2015) One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel. American Journal of Cardiovascular Drugs 15:5, pages 337-350.
Crossref
Crossref
Geoffrey Burnstock & Vera Ralevic. (2013) Purinergic Signaling and Blood Vessels in Health and Disease. Pharmacological Reviews 66:1, pages 102-192.
Crossref
Crossref
Helen M. Parry, Alex S.F. Doney, Colin N.A. Palmer & Chim C. Lang. (2013) State of Play of Pharmacogenetics and Personalized Medicine in Heart Failure. Cardiovascular Therapeutics 31:6, pages 315-322.
Crossref
Crossref
Mike Makris, Joost J. Van Veen, Campbell R. Tait, Andrew D. Mumford & Mike Laffan. (2013) Guideline on the management of bleeding in patients on antithrombotic agents. British Journal of Haematology 160:1, pages 35-46.
Crossref
Crossref